Restaurant Brands International 2Q Profit Rises, Revenue Misses as Growth Slows
By Adriano Marchese
Restaurant Brands International profit rose in the second quarter while revenue growth missed expectations amid a slowdown in growth among its brands, including declining sales from Burger King.
The Canadian-American multinational fast food company that houses the Tim Hortons and Burger King brands, on Thursday logged net income $399 million, or 88 cents a share, up from $351 million, or 77 cents a share, in the comparable quarter a year ago.
Adjusted earnings were 86 cents a share, meeting consensus expectations for the period, according to FactSet.
Sales rose to $2.08 billion from $1.78 billion, just shy of consensus expectations of $2.1 billion.
Restaurant Brands consolidated system-wide sales growth slowed down in the quarter to 5%, compared with a growth of 14% a year earlier.
While all its brands saw lower sales growth, Burger King logged a decline of 0.7%, compared with a growth of 8.1%.
Tim Hortons growth came in at 5.4%, down from 12.1%, and its international segment grew by 9.2%, down from 21.5% a year earlier.
On a comparable basis, consolidated sales growth was 1.9%, down from 9.6%.
Write to Adriano Marchese at adriano.marchese@wsj.com
(END) Dow Jones Newswires
August 08, 2024 07:37 ET (11:37 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks